Spots Global Cancer Trial Database for Evaluation of Predictive Proteic Profile on Mortality in the Acute Phase of Septic Shock in Cancer Patients

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Evaluation of Predictive Proteic Profile on Mortality in the Acute Phase of Septic Shock in Cancer Patients

Official Title: Evaluation of Predictive Proteic Profile on Mortality in the Acute Phase of Septic Shock in Cancer Patients

Study ID: NCT00930085

Conditions

Sepsis

Septic Shock

Cancer

Interventions

SELDI-TOF MS for plasmatic proteic profile

Study Description

Brief Summary: The mortality induced by infections in onco-hematological patients is abnormally high at the acute phase of septic shock. Consequently, it is important to detect the population with a high risk of short term mortality among patients with a septic shock. The aim of this study is the evaluation of predictive proteic profile on the short term mortality in the acute phase of septic shock in cancer patients.

Detailed Description: Method: Monocentric prospective study with diagnostic and prognostic expectations. Primary objective: Identification and characterization of early proteic biomarkers predictive of short term mortality in cancer patients with septic shock. Secondary objective: Research of clinical and biological prognostic factors.